by Pill Pals | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Shirlene T.S. de Lima1, Xinyi Hua1, Ingra M. Claro1, Carlos Garcia Filho, Leda M. Simões...
by Pill Pals | Mar 12, 2025 | News
This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes. The applications are listed by date of approval in reverse chronological order.Trade Name/Proper...
by Pill Pals | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: National Institute of Allergy and Infectious Diseases, Hamilton, Montana,...
by Pill Pals | Mar 12, 2025 | News
FDA considers advancing the availability of evidence-based guidelines for opioid analgesics and other medications with abuse potential a high-impact opportunity to support the safe use of these products. In alignment with the FDA Overdose Prevention Framework priority...
by Pill Pals | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.K....
by Pill Pals | Mar 12, 2025 | News
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Virology Department, AP-HP, Hôpital Saint-Louis, Paris, France (M....